DAC raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-18. Anything still debated is marked as such rather than presented as settled.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (no linker) | ~3.37 kDa | Calculated from peptide sequence |
| Molecular weight (with linker) | ~3.65 kDa | Includes albumin-binding moiety |
| Appearance | White to off-white powder | Typically lyophilized |
| Solubility | Soluble in water | Also dissolves in aqueous buffers |
| Common synonyms | Modified GRF(1-29), DAC:GRF | Usage varies by source |
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
is the concentration of IgG in the plasma compartment. Due to the high FcRn expression levels typically reported (see Fan et al., 2019) and used in PBPK models the expression for clearance is essentially constant for typical therapeutic doses.
==== Nanodiamonds ==== Nanodiamonds (NDs) are carbon nanoparticles which can vary from ~4-100 nm in diameter. NDs are typically formed in two ways: from micron-sized diamond particles under high-pressure high-temperature conditions, called high-pressure high-temperature nanodiamonds (HPHT NDs) and by shock-wave compression, called detonation nanodiamonds (DNDs). The surfaces of these NDs can be modified by processes such as oxidation and aminification to alter adsorption properties.
In response, the Greenlandic prime minister Jens-Frederik Nielsen stated that Greenland had no wish to become part of the US. Trump proceeded to threaten him and denied he knew Nielsen. Trump officials again threatened that the American president could take action against Greenland within weeks.
Macrophages () are a type of white blood cell of the innate immune system that engulf and digest pathogens, such as cancer cells, microbes, cellular debris and foreign substances, which do not have proteins that are specific to healthy body cells on their surface. This self-protection method can be contrasted with that employed by natural killer cells. This process of engulfment and digestion is called phagocytosis; it acts to defend the host against infection and injury. Macrophages are found in essentially all tissues, where they patrol for potential pathogens by amoeboid movement. They take various forms (with various names) throughout the body (e.g., histiocytes, Kupffer cells, alveolar macrophages, microglia, and others), but all are part of the mononuclear phagocyte system. Besides phagocytosis, they play a critical role in nonspecific defense (innate immunity) and also help initiate specific defense mechanisms (adaptive immunity) by recruiting other immune cells such as lymphocytes. For example, they are important as antigen presenters to T cells. In humans, dysfunctional macrophages cause severe diseases such as chronic granulomatous disease that result in frequent infections. Beyond increasing inflammation and stimulating the immune system, macrophages also play an important anti-inflammatory role and can decrease immune reactions through the release of cytokines. Macrophages that encourage inflammation are called M1 macrophages, whereas those that decrease inflammation and encourage tissue repair are called M2 macrophages.
Sources: en.wikipedia.org
=== Foreign political and diplomatic figures === Henry Cruger* (1758), member of the Parliament of Great Britain 1774–1790 and the New York State Senate Isaac Wilkins (1760), judge, member of the Nova Scotia House of Assembly Thomas Henry Barclay (1772), United Empire Loyalist; member of the 6th General Assembly of Nova Scotia Tang Shaoyi* (1882), first premier of the Republic of China William Sanford Evans (1895), Manitoba politician, mayor of Winnipeg 1909–1911 Pixley ka Isaka Seme (1906), founder and president of the African National Congress Wellington Koo (1909), president of the Republic of China and China's ambassador to the United States; Chinese delegate to the Paris Peace Conference, 1919 and the League of Nations; judge on the International Court of Justice 1957–1967 Jun Ke Choy (1915), former mayor of Hangzhou, chairman of China Merchants Group, and founder of the Chinese Culture Center Yu Tsune-chi (1922), Chinese ambassador to Italy and Spain, delegate to the San Francisco Conference, United Nations and the International Labour Organization Mario Laserna Pinzón (1948), Colombian diplomat and educator; founded the Universidad de Los Andes Colin Hughes (1949), first commissioner of the Australian Electoral Commission Uldis-Ivars Grava (1958), Latvian parliamentarian, former director of Latvijas Televīzija and chairman of American Latvian Association Johan Jorgen Holst (1960), Norwegian minister of Defence and Foreign Affairs; heavily involved with the Oslo Accords Yossi Alpher (1964), former Mossad officer and director of the Jaffee Center for Strategic Studies at Tel Aviv University Dore Gold (1975), Israeli political advisor and diplomat; former ambassador to the United States Toomas Hendrik Ilves (1975), president of Estonia Carson Wen (1975), three-time Hong Kong deputy to the National People's Congress and former vice chairman of the Democratic Alliance for the Betterment and Progress of Hong Kong Geoffrey Onyeama (1977), Nigerian minister of Foreign Affairs since 2015, son of Nigerian justice Charles Onyeama Michael Oren (1977), Israeli historian and former Israeli ambassador to the United States Miloon Kothari (1979), United Nations special rapporteur on adequate housing Kim Hyun-jong (1981), former South Korean minister of Trade and Special Advisor to President Moon Jae-in Ken Ofori-Atta (1984), Ghanaian economist and investment banker and current minister for Finance and Economic Planning, member of the Ofori-Atta family Akiva Tor (1985), Israeli ambassador to South Korea Abdullah bin Khalid bin Sultan Al Saud (2010), Saudi Arabia's permanent representative to the United Nations in Vienna, ambassador to Austria, Slovakia and Slovenia, great-grandson of Ibn Saud
== Jung's wound == Scholars suggest that Jung's childhood vulnerabilities compelled him to heal his own life. Jung stated that "certain psychic disturbances can be extremely infectious if the doctor himself has a latent predisposition in that direction...For this reason he runs a risk - and must run it in the nature of things". Further he stated that "it is no loss, either, if [the analyst] feels that the patient is hitting him, or even scoring off him: it is his own hurt that gives the measure of his power to heal". Jungians acknowledge that Jung's own wounds could cause damage to those he was attempting to heal.
CBD is a 5-HT1A receptor agonist, which is under laboratory research to determine if it has an anxiolytic effect. It is often claimed that sativa strains provide a more stimulating psychoactive high while indica strains are more sedating with a body high. However, this is disputed by researchers. There is currently no consistent evidence that cannabis with higher CBD to THC ratios reduced THC induced psychotic symptoms . A 2015 review found that the use of high CBD-to-THC strains of cannabis showed better cognitive function and both lower risk for developing psychosis, as well as a later age of onset of the illness, compared to cannabis with low CBD-to-THC ratios.
In the salivary glands, fluid is primarily secreted into small cavities surrounded by a small clusters of 8-12 cells, called an acinus (plural: acini), and these cells are often referred to as acinar cells. In the acini of the salivary glands, the serous acinar cells secrete a watery fluid with a high concentration of proteins such as enzymes (like α-Amylase) and anti-microbial proteins (like lactoperoxidase), unlike the mucous acinar cells, which produce thicker mucus-rich fluid. After secretion, the secreted fluid passes through a series of ducts which are lined with cells that further modify its composition and eventually release the finished saliva into the mouth.
The above examples envisage nuclear warfare at a strategic level, i.e., total war. However, nuclear powers have the ability to undertake more limited engagements. "Sub-strategic use" includes the use of either "low-yield" tactical nuclear weapons, or of variable yield strategic nuclear weapons in a very limited role, as compared to exchanges of larger-yield strategic nuclear weapons over major population centers. This was described by the UK Parliamentary Defence Select Committee as "the launch of one or a limited number of missiles against an adversary as a means of conveying a political message, warning or demonstration of resolve". It is believed that all current nuclear weapons states possess tactical nuclear weapons, with the exception of the United Kingdom, which decommissioned its tactical warheads in 1998. However, the UK does possess scalable-yield strategic warheads, and this technology tends to blur the difference between "strategic", "sub-strategic", and "tactical" use or weapons. American, French and British nuclear submarines are believed to carry at least some missiles with dial-a-yield warheads for this purpose, potentially allowing a strike as low as one kiloton (or less) against a single target. Only the People's Republic of China and the Republic of India have declarative, unqualified, unconditional "no first use" nuclear weapons policies. India and Pakistan maintain only a credible minimum deterrence.
Sources: en.wikipedia.org
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.
Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.
The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.